The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Guardant Health Inc. | COM | 40131M109 | 1,569,163 | 14,037,960 | SH | DFND | 0 | 14,037,960 | 0 | ||
Uber Technologies Inc. | COM | 90353T100 | 8,106,884 | 222,228,178 | SH | DFND | 0 | 174,320,883 | 47,907,295 | ||
VIR Biotechnology Inc. | COM | 92764N102 | 776,430 | 22,616,666 | SH | DFND | 0 | 22,616,666 | 0 | ||
Relay Therapeutics | COM | 75943R102 | 1,188,472 | 27,904,963 | SH | DFND | 0 | 27,904,963 | 0 |